Nature Communications (Dec 2022)
A pH-responsive T1-T2 dual-modal MRI contrast agent for cancer imaging
Abstract
Magnetic resonance imaging (MRI) is a well-established non-invasive medical imaging technology. Here, to improve the performance of the technique, the authors describe the design of a pH-responsive T1-T2 dual-modal MRI contrast agent, showing enhanced imaging sensitivity in preclinical cancer models.